{"id":650043,"date":"2023-05-02T17:10:01","date_gmt":"2023-05-02T17:10:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=650043"},"modified":"2023-05-02T17:10:01","modified_gmt":"2023-05-02T17:10:01","slug":"celiac-disease-cd-market-analysis-market-size-epidemiology-leading-companies-companies-provention-bio-falk-pharma-and-zedira-precigen-actobio-takeda","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/celiac-disease-cd-market-analysis-market-size-epidemiology-leading-companies-companies-provention-bio-falk-pharma-and-zedira-precigen-actobio-takeda_650043.html","title":{"rendered":"Celiac Disease (CD) Market Analysis, Market Size, Epidemiology, Leading Companies | Companies – Provention Bio, Falk Pharma and Zedira, Precigen ActoBio, Takeda"},"content":{"rendered":"
\n
\"Celiac<\/a><\/div>\n
\n
Celiac Disease Market<\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s \u201cCeliac Disease (CD)\u2013Market Insights, Epidemiology, and Market Forecast-2032\u201d report delivers an in-depth understanding of the Celiac Disease (CD), historical and forecasted epidemiology as well as the Celiac Disease (CD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n

DelveInsight has launched a new report on “Celiac Disease (CD)-Market Insights, Epidemiology, and Market Forecast-2032”.<\/p>\n

DelveInsight’s “Celiac Disease (CD)–Market Insights, Epidemiology, and Market Forecast-2032<\/a><\/strong>” report delivers an in-depth understanding of the Celiac Disease (CD), historical and forecasted epidemiology as well as the Celiac Disease (CD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

Some of the key facts of the Celiac Disease Market Report<\/a>:<\/strong><\/p>\n

 <\/p>\n

    \n
  1. The total prevalent population of CD in the 7 major markets was found to be 6,334,000 in 2019. The total 7MM diagnosed prevalent cases of CD in 2019 were 1,303,000 out of which the highest diagnosed prevalent cases of this disease were seen in the United States, which was 661,000. <\/li>\n
  2. DelveInsight has found 238,000 and 423,000 cases of males and females in the United States, in 2019. <\/li>\n
  3. It was found that in the United States the number of cases of Classical, Non-classical and Sub-clinical was 178,000, 343,000 and 138,861 respectively, in 2019. <\/li>\n
  4. In the EU5 countries, the total prevalent population of CD was found to be maximum in Germany with 738,357 cases, followed by the United Kingdom with 650,676 cases in 2019. <\/li>\n
  5. While, the least number of cases were found in Spain, i.e.421,000 in 2019.<\/li>\n
  6. In Japan, the prevalence of CD was found to be 65,000 in 2019.<\/li>\n<\/ol>\n

    Key benefits of the report:<\/strong><\/p>\n

    1.The Celiac Disease (CD) market report covers a descriptive overview and comprehensive insight of the Celiac Disease (CD) Epidemiology and Celiac Disease (CD) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/p>\n

    2.The Celiac Disease (CD) market report provides insights into the current and emerging therapies.<\/p>\n

    3.Celiac Disease (CD) market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/p>\n

    4.The Celiac Disease (CD) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Celiac Disease (CD) market.<\/p>\n

    Request for sample pages: https:\/\/www.delveinsight.com\/sample-request\/celiac-disease-cd-market<\/a><\/strong><\/p>\n

    Celiac Disease (CD): Overview<\/strong><\/p>\n

    Celiac disease (CD) is a common disorder that is estimated to affect about one percent of the population. It is a condition in which the absorptive surface of the small intestine is damaged by a substance called gluten. Gluten is a group of proteins present in wheat, rye and barley and their cross bred grains.<\/p>\n

    The key players involved in the Celiac Disease (CD) market<\/a>:<\/strong><\/p>\n

     <\/p>\n

      \n
    1. ImmunoGenX<\/li>\n
    2. 9 Meters Biopharma<\/li>\n
    3. Cour Pharmaceutical\/ Takeda<\/li>\n
    4. Provention Bio<\/li>\n
    5. Falk Pharma and Zedira<\/li>\n
    6. Precigen ActoBio<\/li>\n
    7. Takeda<\/li>\n<\/ol>\n

      The launch of the emerging therapies is expected to significantly impact the  Celiac Disease (CD) treatment scenario in the upcoming years:-<\/strong><\/p>\n

      Drug covered<\/strong><\/p>\n

        \n
      1. Latiglutenase (IMGX003)<\/li>\n
      2. Larazotide Acetate<\/li>\n
      3. CNP-101\/ TAK-101<\/li>\n
      4. PRV-015 (AMG 714)<\/li>\n
      5. ZED1227<\/li>\n
      6. AG017<\/li>\n
      7. TAK-062<\/li>\n<\/ol>\n

        Request a free sample report @https:\/\/www.delveinsight.com\/sample-request\/celiac-disease-cd-market<\/a><\/strong><\/p>\n

        Table of Contents<\/strong><\/p>\n

        1. Report Introduction<\/p>\n

        2. Executive Summary<\/p>\n

        3. SWOT analysis<\/p>\n

        4. Celiac Disease (CD) Patient Share (%) Overview at a Glance<\/p>\n

        5. Celiac Disease (CD) Market Overview at a Glance<\/p>\n

        6. Celiac Disease (CD) Disease Background and Overview<\/p>\n

        7. Celiac Disease (CD) Epidemiology and Patient Population<\/p>\n

        8. Country-Specific Patient Population of Celiac Disease (CD) <\/p>\n

        9. Celiac Disease (CD) Current Treatment and Medical Practices<\/p>\n

        10. Unmet Needs<\/p>\n

        11. Celiac Disease (CD) Emerging Therapies<\/p>\n

        12. Celiac Disease (CD) Market Outlook<\/p>\n

        13. Country-Wise Celiac Disease (CD) Market Analysis (2019–2032)<\/p>\n

        14. Market Access and Reimbursement of Therapies<\/p>\n

        15. Market drivers<\/p>\n

        16. Market barriers<\/p>\n

        17. Appendix<\/p>\n

        18. Celiac Disease (CD) Report Methodology<\/p>\n

        19. DelveInsight Capabilities<\/p>\n

        20. Disclaimer<\/p>\n

        21. About DelveInsight<\/p>\n

        Media Contact<\/span>
        Company Name:<\/strong>         DelveInsight Business Research LLP<\/a>
        Contact Person:<\/strong> Kritika Rehani
        Email:<\/strong>         Send Email<\/a>
        Phone:<\/strong> 9193216187
        Address:<\/strong>304 S. Jones Blvd #2432
        City:<\/strong> Las Vegas
        State:<\/strong> Nevada
        Country:<\/strong> United States
        Website:<\/strong>         https:\/\/www.delveinsight.com\/<\/a><\/p>\n

        <\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

        Celiac Disease Market DelveInsight\u2019s \u201cCeliac Disease (CD)\u2013Market Insights, Epidemiology, and Market Forecast-2032\u201d report delivers an in-depth understanding of the Celiac Disease (CD), historical and forecasted epidemiology as well as the Celiac Disease (CD) market trends in the United States, EU5 … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-650043","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/650043","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=650043"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/650043\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=650043"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=650043"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=650043"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}